Agfa-Gevaert N.V. Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 173

Agfa-Gevaert N.V. Market Share Analysis

Summary

GlobalData’s new report, “Agfa-Gevaert N.V. Market Share Analysis” provides in-depth information on Agfa-Gevaert N.V. .’s market position in the different medical equipment markets it operates in. The report provides Agfa-Gevaert N.V. . market share information in two key market categories – Clinical IT Systems and Medical imaging information systems. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets Agfa-Gevaert N.V. . operates in – Healthcare IT
- Agfa-Gevaert N.V. .’s company shares (in Revenues) information for all the key countries the company has presence in – United Kingdom, France, Spain, Germany, Italy, China, Australia, Japan, India, United States, Canada and Brazil.
- Agfa-Gevaert N.V. .’s company shares (in Revenues) information for all the key market categories the company has presence in – Clinical IT Systems and Medical imaging information systems.
- All the key data-points are for 2011 and cover all the key regions – North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, Agfa-Gevaert N.V. . operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Agfa-Gevaert N.V. .’s market positions.

Agfa-Gevaert N.V. Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Healthcare IT 11
3.1.1 Clinical IT Systems 11
3.1.2 Medical Imaging Information Systems 11
4 Company Snapshot 12
4.1 Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Graphics Segment 13
5.2.1 Overview 13
5.2.2 Financials 14
5.2.3 Capital Expenditure 14
5.3 HealthCare Segment 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Capital Expenditure 14
5.4 Specialty Products Segment 15
5.4.1 Overview 15
5.4.2 Financials 15
5.4.3 Capital Expenditure 15
5.5 Major Products and Services 16
5.5.1 Overview 16
6 History 24
7 SWOT Analysis 31
7.1 Overview 31
7.2 Agfa-Gevaert N.V. Strengths 31
7.2.1 Diversified Operations 31
7.2.2 Focused Research and Development Capabilities 32
7.2.3 Geographical Diversity 32
7.3 Agfa-Gevaert N.V. Weaknesses 32
7.3.1 Decline in Profitability Ratios 32
7.3.2 Product Callbacks 33
7.4 Agfa-Gevaert N.V. Opportunities 33
7.4.1 Strategic Alliances/Contracts 33
7.4.2 Inorganic Growth Strategy 34
7.4.3 Growing Healthcare IT Market 34
7.4.4 Rising Healthcare Expenditure in the US 34
7.5 Agfa-Gevaert N.V. Threats 34
7.5.1 Stringent Government Regulations 34
7.5.2 Changing Technological Trends 35
7.5.3 Cost Containment Pressures 35
8 Competitors 36
9 Competitive Landscape 38
9.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 38
9.2 Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Region, Market Share (2011) 40
9.3 Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 41
9.4 Healthcare IT (Medical imaging information systems), Global, Market Share (%), 2011 43
9.5 Agfa-Gevaert N.V., Healthcare IT (Medical imaging information systems), by Region, Market Share (2011) 45
9.6 Agfa-Gevaert N.V., Healthcare IT (Medical imaging information systems), by Country, Market Share (2011) 46
9.7 Agfa-Gevaert N.V., Healthcare IT, Global, Category Revenue Share (2011) 48
9.8 Agfa-Gevaert N.V., Asia-Pacific, Category Revenue Share (2011) 50
9.8.1 Agfa-Gevaert N.V., Australia, Category Revenue Share (2011) 51
9.8.2 Agfa-Gevaert N.V., China, Category Revenue Share (2011) 52
9.8.3 Agfa-Gevaert N.V., India, Category Revenue Share (2011) 53
9.8.4 Agfa-Gevaert N.V., Japan, Category Revenue Share (2011) 54
9.8.5 Agfa-Gevaert N.V., Other Asia-Pacific, Category Revenue Share (2011) 55
9.9 Agfa-Gevaert N.V., Europe, Category Revenue Share (2011) 56
9.9.1 Agfa-Gevaert N.V., France, Category Revenue Share (2011) 58
9.9.2 Agfa-Gevaert N.V., Germany, Category Revenue Share (2011) 60
9.9.3 Agfa-Gevaert N.V., Italy, Category Revenue Share (2011) 62
9.9.4 Agfa-Gevaert N.V., Spain, Category Revenue Share (2011) 64
9.9.5 Agfa-Gevaert N.V., United Kingdom, Category Revenue Share (2011) 66
9.9.6 Agfa-Gevaert N.V., Other Europe, Category Revenue Share (2011) 67
9.10 Agfa-Gevaert N.V., Middle East and Africa, Category Revenue Share (2011) 69
9.11 Agfa-Gevaert N.V., North America, Category Revenue Share (2011) 70
9.11.1 Agfa-Gevaert N.V., Canada, Category Revenue Share (2011) 71
9.11.2 Agfa-Gevaert N.V., United States, Category Revenue Share (2011) 72
9.12 Agfa-Gevaert N.V., South and Central America, Category Revenue Share (2011) 73
9.12.1 Agfa-Gevaert N.V., Brazil, Category Revenue Share (2011) 74
10 Key Employees 75
11 Key Employee Biographies 76
12 Company Statement 77
13 Locations And Subsidiaries 79
13.1 Head Office 79
13.2 Other Locations & Subsidiaries 79
14 Financial Deals Landscape 81
14.1 Agfa-Gevaert N.V., Deals Volume Summary, 2006 to YTD 2012 81
15 Agfa-Gevaert N.V. Detailed Deal Summary 83
15.1 Partnerships 83
15.1.1 Agfa HealthCare Enters Into Agreement With Tribvn To Offer Pathology Imaging Solution 83
15.1.2 Agfa Healthcare Enters Into Technology Integration Agreement With Schiller America 85
15.1.3 Agfa HealthCare Signs Co-Marketing Agreement With Forcare 86
15.1.4 Agfa HealthCare Enters Into An Agreement With TeraRecon 88
15.1.5 Agfa HealthCare Enters Into An Agreement With TomTec Imaging Systems 90
15.1.6 Agfa HealthCare Signs Co-Marketing Agreement With Skipton 92
15.1.7 Agfa HealthCare Signs Agreement With peerVue 94
15.1.8 Agfa HealthCare Signs Agreement With Cedaron Medical 96
15.1.9 Agfa HealthCare Signs An Agreement With Segami 98
15.1.10 Agfa HealthCare Signs An Agreement With MEDIAN Technologies 100
15.1.11 Agfa HealthCare Enters Into Co-Marketing Agreement With Nexsan 102
15.1.12 Agfa HealthCare Signs An Agreement With Meridian Technique 104
15.1.13 Agfa HealthCare Signs An Agreement With Amirsys 106
15.1.14 Agfa HealthCare Enters Into An Integration Agreement With Visage Imaging 108
15.1.15 Agfa HealthCare Signs Agreement With InterComponentWare 110
15.1.16 I-Science International Signs An Agreement With AGFA Healthcare 112
15.1.17 iCAD Signs An Agreement With Agfa Healthcare 114
15.1.18 Agfa HealthCare Signs An Agreement With Vocada 116
15.1.19 Agfa HealthCare Enters Into An Agreement With InterComponentWare 118
15.1.20 Agfa HealthCare Enters Into Research Agreement With Free University of Brussels 120
15.1.21 Agfa HealthCare Signs An Agreement With MEDSEEK 122
15.2 Equity Offering 124
15.2.1 Agfa-Gevaert Completes Rights Offering For $205 Million 124
15.3 Acquisition 126
15.3.1 Agfa HealthCare Acquires WPD Informatica, Healthcare IT Company 126
15.3.2 UBS Acquires 3.55% Stake In Agfa-Gevaert, Healthcare IT Company 128
15.3.3 Agfa HealthCare Acquires Insight Agents From Curagita Holding 129
15.3.4 BioClinica Acquires CardioNow From Agfa HealthCare 131
15.3.5 Agfa-Gevaert Acquires Hydmedia From Heydt-Verlags 133
16 Recent Developments 134
16.1 Financial Announcements 134
16.1.1 Nov 14, 2012: Agfa-Gevaert Reports Revenue Of €766m In Q3 2012 134
16.1.2 Aug 22, 2012: Agfa-Gevaert Reports Revenue Of €779m In Q2 2012 135
16.1.3 May 09, 2012: Agfa-Gevaert Reports Revenue Of €734m In Q1 2012 135
16.1.4 Mar 07, 2012: Agfa-Gevaert Reports Revenue Of €3 Billion In 2011 136
16.1.5 Nov 16, 2011: Agfa-Gevaert Reports Revenue Of €719m In Q3 2011 137
16.1.6 Aug 24, 2011: Agfa-Gevaert Reports Revenue Of €763m In Q2 2011 138
16.1.7 May 11, 2011: Agfa-Gevaert Reports Revenue Of €736m In Q1 2011 139
16.1.8 Mar 25, 2011: Agfa-Gevaert Reports Revenue Of €2.9 Billion In 2010 139
16.1.9 Nov 24, 2010: Agfa-Gevaert Reports Profit Of EUR16 Million For Q3 2010 140
16.1.10 Aug 25, 2010: Agfa-Gevaert Reports Profit Of EUR39 Million In Q2 2010 141
16.1.11 May 19, 2010: Agfa-Gevaert Reports Revenue Of EUR664 Million In Q1 2010 142
16.1.12 Mar 31, 2010: Agfa-Gevaert Reports Profit Of EUR7 Million In 2009 142
16.1.13 Feb 09, 2010: Agfa-Gevaert Reports Preliminary Q4 2009 Results 143
16.1.14 Oct 30, 2009: Agfa-Gevaert Reports Net Sales Of EUR681 Million In Q3 2009 144
16.1.15 Jul 28, 2009: Agfa-Gevaert Posts Net Revenues Of EUR677 Million In Q2 2009 146
16.1.16 Apr 28, 2009: Agfa-Gevaert Posts Net Loss Of EUR9 Million In Q1 2009 147
16.1.17 Mar 11, 2009: Agfa-Gevaert Reports 2008 Results 148
16.1.18 Oct 30, 2008: Agfa-Gevaert Reports 3Q 2008 Results 149
16.1.19 Jul 30, 2008: Agfa-Gevaert Reports 2Q 2008 Results 151
16.1.20 Apr 29, 2008: Agfa-Gevaert Reports Q1 2008 Results 153
16.1.21 Feb 27, 2008: Agfa-Gevaert Reports Q4 2007 Results 155
16.1.22 Oct 31, 2007: Agfa-Gevaert Reports Q3 2007 Results 157
16.1.23 Jul 31, 2007: Agfa-Gevaert Reports Q2 2007 Results 159
16.1.24 May 03, 2007: Agfa-Gevaert Reports Q1 2007 Results 160
16.1.25 Apr 24, 2007: Agfa-Gevaert Declares Dividend 160
16.1.26 Feb 28, 2007: Agfa-Gevaert Reports Q4 2006 Results 161
16.1.27 Nov 16, 2006: Agfa-Gevaert Reports Q3 Results 161
16.1.28 Aug 24, 2006: Agfa-Gevaert Reports Q2 Results 162
16.2 Corporate Communications 163
16.2.1 Feb 09, 2010: Christian Reinaudo To succeed Jo Cornu As CEO Of Agfa-Gevaert 163
16.2.2 Jun 19, 2008: Agfa-Gevaert Appoints New CFO 164
16.2.3 Apr 25, 2008: Agfa-Gevaert Appoints President, Agfa Materials 164
16.2.4 Apr 11, 2008: Agfa-Gevaert Appoints Group Controller 165
16.2.5 Jan 30, 2008: Agfa-Gevaert Appoints New Board Member 165
16.2.6 Nov 30, 2007: Agfa-Gevaert Appoints New CEO 165
16.3 Other Significant Developments 166
16.3.1 Mar 21, 2012: KGE Delivers 7.4 MW Class Gas Turbine Cogeneration System To Agfa-Gevaert's Plant In Belgium 166
16.3.2 Apr 05, 2011: Aldrich Materials Collaborates With Agfa Materials To Further Expand Organic And Printed Electronics Portfolio 166
17 Appendix 168
17.1 Research Methodology 169
17.2 Secondary Research 169
17.3 Primary Research 170
17.4 Models 170
17.5 Forecasts 170
17.6 Expert Panels 171
17.7 GlobalData Consulting 171
17.8 Currency Conversion 172
17.9 Contact Us 173
17.10 Disclaimer 173

1.1 List of Tables
Table 1: Agfa-Gevaert N.V., Key Facts, 2011 12
Table 2: Agfa-Gevaert N.V., SWOT Analysis, 2011 31
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 39
Table 4: Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 40
Table 5: Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 42
Table 6: Healthcare IT (Medical imaging information systems), Global, Company Share by Revenue ($m), 2011 44
Table 7: Agfa-Gevaert N.V., Healthcare IT (Medical imaging information systems), by Region, Revenue ($m) and Market Share (%), 2011 45
Table 8: Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 47
Table 9: Agfa-Gevaert N.V., Healthcare IT, Global, Revenue ($m) and Market Share (%) by Category, 2011 49
Table 10: Agfa-Gevaert N.V., Healthcare IT, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 50
Table 11: Agfa-Gevaert N.V., Healthcare IT, Australia, Revenue ($m) and Market Share (%) by Category, 2011 51
Table 12: Agfa-Gevaert N.V., Healthcare IT, China, Revenue ($m) and Market Share (%) by Category, 2011 52
Table 13: Agfa-Gevaert N.V., Healthcare IT, India, Revenue ($m) and Market Share (%) by Category, 2011 53
Table 14: Agfa-Gevaert N.V., Healthcare IT, Japan, Revenue ($m) and Market Share (%) by Category, 2011 54
Table 15: Agfa-Gevaert N.V., Healthcare IT, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2011 55
Table 16: Agfa-Gevaert N.V., Healthcare IT, Europe, Revenue ($m) and Market Share (%) by Category, 2011 57
Table 17: Agfa-Gevaert N.V., Healthcare IT, France, Revenue ($m) and Market Share (%) by Category, 2011 59
Table 18: Agfa-Gevaert N.V., Healthcare IT, Germany, Revenue ($m) and Market Share (%) by Category, 2011 61
Table 19: Agfa-Gevaert N.V., Healthcare IT, Italy, Revenue ($m) and Market Share (%) by Category, 2011 63
Table 20: Agfa-Gevaert N.V., Healthcare IT, Spain, Revenue ($m) and Market Share (%) by Category, 2011 65
Table 21: Agfa-Gevaert N.V., Healthcare IT, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2011 66
Table 22: Agfa-Gevaert N.V., Healthcare IT, Other Europe, Revenue ($m) and Market Share (%) by Category, 2011 68
Table 23: Agfa-Gevaert N.V., Healthcare IT, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2011 69
Table 24: Agfa-Gevaert N.V., Healthcare IT, North America, Revenue ($m) and Market Share (%) by Category, 2011 70
Table 25: Agfa-Gevaert N.V., Healthcare IT, Canada, Revenue ($m) and Market Share (%) by Category, 2011 71
Table 26: Agfa-Gevaert N.V., Healthcare IT, United States, Revenue ($m) and Market Share (%) by Category, 2011 72
Table 27: Agfa-Gevaert N.V., Healthcare IT, South and Central America, Revenue ($m) and Market Share (%) by Category, 2011 73
Table 28: Agfa-Gevaert N.V., Healthcare IT, Brazil, Revenue ($m) and Market Share (%) by Category, 2011 74
Table 29: Agfa-Gevaert N.V., Key Employees 75
Table 30: Agfa-Gevaert N.V., Other Locations 79
Table 31: Agfa-Gevaert N.V., Subsidiaries 79
Table 32: Agfa-Gevaert N.V., Deals Volume Summary, 2006 to YTD 2012 81
Table 33: Agfa-Gevaert N.V., Deals Summary, 2006 to YTD 2012 82
Table 34: Agfa HealthCare Enters Into Agreement With Tribvn To Offer Pathology Imaging Solution 83
Table 35: Agfa Healthcare Enters Into Technology Integration Agreement With Schiller America 85
Table 36: Agfa HealthCare Signs Co-Marketing Agreement With Forcare 86
Table 37: Agfa HealthCare Enters Into An Agreement With TeraRecon 88
Table 38: Agfa HealthCare Enters Into An Agreement With TomTec Imaging Systems 90
Table 39: Agfa HealthCare Signs Co-Marketing Agreement With Skipton 92
Table 40: Agfa HealthCare Signs Agreement With peerVue 94
Table 41: Agfa HealthCare Signs Agreement With Cedaron Medical 96
Table 42: Agfa HealthCare Signs An Agreement With Segami 98
Table 43: Agfa HealthCare Signs An Agreement With MEDIAN Technologies 100
Table 44: Agfa HealthCare Enters Into Co-Marketing Agreement With Nexsan 102
Table 45: Agfa HealthCare Signs An Agreement With Meridian Technique 104
Table 46: Agfa HealthCare Signs An Agreement With Amirsys 106
Table 47: Agfa HealthCare Enters Into An Integration Agreement With Visage Imaging 108
Table 48: Agfa HealthCare Signs Agreement With InterComponentWare 110
Table 49: I-Science International Signs An Agreement With AGFA Healthcare 112
Table 50: iCAD Signs An Agreement With Agfa Healthcare 114
Table 51: Agfa HealthCare Signs An Agreement With Vocada 116
Table 52: Agfa HealthCare Enters Into An Agreement With InterComponentWare 118
Table 53: Agfa HealthCare Enters Into Research Agreement With Free University of Brussels 120
Table 54: Agfa HealthCare Signs An Agreement With MEDSEEK 122
Table 55: Agfa-Gevaert Completes Rights Offering For $205 Million 124
Table 56: Agfa HealthCare Acquires WPD Informatica, Healthcare IT Company 126
Table 57: UBS Acquires 3.55% Stake In Agfa-Gevaert, Healthcare IT Company 128
Table 58: Agfa HealthCare Acquires Insight Agents From Curagita Holding 129
Table 59: BioClinica Acquires CardioNow From Agfa HealthCare 131
Table 60: Agfa-Gevaert Acquires Hydmedia From Heydt-Verlags 133
Table 61: USD to Local Currency, Average Exchange Rate, 2011 172

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 38
Figure 2: Agfa-Gevaert N.V., Healthcare IT (Clinical IT Systems), by Country, Market Share (%), 2011 41
Figure 3: Healthcare IT (Medical imaging information systems), Global, Market Share (%), 2011 43
Figure 4: Agfa-Gevaert N.V., Healthcare IT (Medical imaging information systems), by Region, Market Share (%), 2011 45
Figure 5: Agfa-Gevaert N.V., Healthcare IT (Medical imaging information systems), by Country, Market Share (%), 2011 46
Figure 6: Agfa-Gevaert N.V., Healthcare IT, Global, Category Revenue Share (%), 2011 48
Figure 7: Agfa-Gevaert N.V., Healthcare IT, Global, Market Share (%) by Category, 2011 49
Figure 8: Agfa-Gevaert N.V., Healthcare IT, Europe, Category Revenue Share (%), 2011 56
Figure 9: Agfa-Gevaert N.V., Healthcare IT, Europe, Market Share (%) by Category, 2011 57
Figure 10: Agfa-Gevaert N.V., Healthcare IT, France, Category Revenue Share (%), 2011 58
Figure 11: Agfa-Gevaert N.V., Healthcare IT, France, Market Share (%) by Category, 2011 59
Figure 12: Agfa-Gevaert N.V., Healthcare IT, Germany, Category Revenue Share (%), 2011 60
Figure 13: Agfa-Gevaert N.V., Healthcare IT, Germany, Market Share (%) by Category, 2011 61
Figure 14: Agfa-Gevaert N.V., Healthcare IT, Italy, Category Revenue Share (%), 2011 62
Figure 15: Agfa-Gevaert N.V., Healthcare IT, Italy, Market Share (%) by Category, 2011 63
Figure 16: Agfa-Gevaert N.V., Healthcare IT, Spain, Category Revenue Share (%), 2011 64
Figure 17: Agfa-Gevaert N.V., Healthcare IT, Spain, Market Share (%) by Category, 2011 65
Figure 18: Agfa-Gevaert N.V., Healthcare IT, Other Europe, Category Revenue Share (%), 2011 67
Figure 19: Agfa-Gevaert N.V., Healthcare IT, Other Europe, Market Share (%) by Category, 2011 68
Figure 20: Agfa-Gevaert N.V., Deals Volume Summary, 2006 to YTD 2012 81

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 64
    GlobalData's clinical trial report, "Cerebral (Fatal) Malaria Global Clinical Trials Review, H2, 2014" provides data on the Cerebral (Fatal) Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral (Fatal) Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase,......
  • African Trypanosomiasis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 48
    GlobalData's clinical trial report, "African Trypanosomiasis Global Clinical Trials Review, H2, 2014" provides data on the African Trypanosomiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on African Trypanosomiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, tr......
  • Cryptosporidiosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 58
    GlobalData's clinical trial report, "Cryptosporidiosis Global Clinical Trials Review, H2, 2014" provides data on the Cryptosporidiosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptosporidiosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, promin......
  • Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 70
    GlobalData's clinical trial report, "Cytomegalovirus (CMV) Retinitis Global Clinical Trials Review, H2, 2014" provides data on the Cytomegalovirus (CMV) Retinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (CMV) Retinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical t......
  • Dermatophytosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 86
    GlobalData's clinical trial report, "Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence o......
  • Bacterial Sepsis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 65
    GlobalData's clinical trial report, "Bacterial Sepsis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominenc......
  • Anthrax Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 79
    GlobalData's clinical trial report, "Anthrax Global Clinical Trials Review, H2, 2014" provides data on the Anthrax clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anthrax. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also ......
  • Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 65
    GlobalData's clinical trial report, "Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014" provides data on the Chagas Disease (American Trypanosomiasis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Disease (American Trypanosomiasis). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ......
  • Bacterial Vaginosis Global Clinical Trials Review, H2, 2014
    Published: 21-Nov-2014        Price: US $2500 Onwards        Pages: 79
    GlobalData's clinical trial report, "Bacterial Vaginosis Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Vaginosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Vaginosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs